5-FC, ANTIBIOTIC LEVEL
50-100 MCG/ML 1 HOUR POST DOSE
ACETAMINOPHEN,SERUM
10-20 MG/L
HEPATOTOXICITY LIKELY WITH LEVELS ABOVE
200 MG/L 4 HRS. POST INGESTION.
TOP
AFP TUMOR MARKER - TOSOH
0-10 NG/ML
ALANINE AMINO TRANS. (SGPT)
ADULTS: 0-30 IU/L (37°C)
ALBUMIN, SERUM
3.5-5.3 G/DL
AMIKACIN, ANTIBIOTIC LEVEL
PRE-DOSE <10 MCG/ML POST-DOSE (1 HR)
15-35 MCG/ML
TOP
AMITRIPTYLINE (INC NORTRIP.)
AMITRIPTYLINE + NORTRIPTYLINE: 120-250 NG/ML
AMMONIA, BLOOD
0-50 UMOL/L
AMYLASE,SERUM
NEWBORN: 0-44 U/L (37°C)
ADULT: 0-88 U/L (37°C)
ANTI-CENTROMERE SCREEN & TITR
NEGATIVE
ANTI-DNA SCREEN & TITER
NEGATIVE
ANTI-JO-1
NEGATIVE.
ANTI-RNP & ANTI-SM TESTS
NEGATIVE
TOP
ANTI-RO (SS-A)&ANTI-LA; (SS-B)
NEGATIVE
ANTI-SCL-70
NEGATIVE
ANTINUCLEAR ANTIBODY SCREEN
NEGATIVE
COMMENT: SIGNIFICANT TITER 1:160
APTT
21.2 - 30.8
TOP
ASPARTATE AMINO TRANS. (SGOT)
ADULTS: 0-35 IU/L (37°C)
BARBITURATE IDENT,BLOOD,EMER.
PENTOBARBITAL: 1-5 MG/L, >10 MG/L TOXIC
HIGHER LEVELS ARE UTILIZED IN INTRACRANIAL
THERAPY (UP TO 30 MG/L)
BILIRUBIN, DIRECT, SERUM
0 - 0.4 MG/DL
BILIRUBIN, TOTAL, SERUM
ADULTS: 0.2-1.2 MG/DL
BLOOD GASES (PH,PCO2,PO2) EMER
PH: 7.35-7.45
PCO2: 35-45 MM HG
PO2: 75-100 MM HG
CALCULATED BICARBONATE: 18-23 MMOL/L
C1 ESTERASE INHIB. IMMUNODIFF
DETECTABLE AT EQUAL OR MORE THAN 1:2 DILUTION.
TOP
C3 AND C4, SERUM
ADULT: C3 83-177 MG/DL
ADULT: C4 15- 45 MG/DL
PEDIATRIC: C3 C4
AGE (MG/DL) (MG/DL)
NEWBORN 57 - 116 7 - 23
1 - 3 MOS 53 - 149 7- 28
4 - 6 MOS 62 - 175 7 - 42
7 - 9 MOS 5 - 166 10 - 37
10 - 12 MOS 73 - 180 12 - 39
1 - 2 YRS 84 - 174 12 - 40
2 - 3 YRS 81 - 170 9 - 34
3 - 4 YRS 77 - 171 10 - 36
4 - 5 YRS 86 - 166 13 - 32
6 - 8 YRS 88 - 155 12 - 32
9 - 10 YRS 89 - 195 10 - 40
ADULT 83 - 177 15 - 45
COMPUTER REPORTING DEFAULT RANGE
(IF AGE NOT KNOWN):
C3 = 53 - 195 MG/DL
C4 = 7 - 45 MG/DL
TOP
C3-COMPLEMENT,SERUM
ADULT 83 - 177 MG/DL
PEDIATRIC - SEE C3 AND C4, SERUM.
C4-COMPLEMENT,SERUM
ADULT: 15 - 45 MG/DL
PEDIATRIC: SEE C3 AND C4, SERUM.
CALCIUM,IONIZED,WHOLE BLOOD
1.13-1.32 MMOL/L
CALCIUM,SERUM
ADULTS: 8.4-10.5 MG/DL
CANCER ANTIGEN (CA-125)
0-35 U/ML
CARBAMAZEPINE-TEGRETOL,SERUM
THERAPEUTIC RANGE: 8-12 MG/L
CARBON DIOXIDE,SERUM
ADULT: 24-30 MEQ/L
PEDIATRIC: 20-24 MEQ/L
CARBON MONOXIDE BLOOD,EMER.
NONSMOKERS: 0 - 2% OF TOTAL HGB
SMOKERS: 2 - 10% OF TOTAL HGB
TOXIC: 20 - 60% OF TOTAL HGB
LETHAL: > 60% OF TOTAL HGB
TOP
CARCINOEMBRYONIC AG (CEA)
<3.0 NG/ML (NON-SMOKERS)
<5.0 NG/ML (SMOKERS)
CD2(T11) TOTAL T CELLS
ADULT RANGE: 70 - 94%
CD20(B1) MATURE LYMPHOCYTES
CD3(T3) MATURE T CELLS
ADULT RANGE: 57 - 91%
CD4/CD3 LYMPHOCYTE RATIO
ADULT RANGE: CD4 = 32 - 68%
CD3 = 57 - 91%
CD4/CD8 LYMPHOCYTE RATIO
ADULT RANGE: CD4 = 32 - 68%
CD3 = 57 - 91%
CD8 = 10 - 36%
CD56 NATURAL KILLER CELLS
CHEMISTRY PANEL,SERUM
REFER TO INDIVIDUAL TESTS
CHLORAMPHENICOL, ANTIBIOT LEVL
10-20 MCG/ML 1 HOUR POST DOSE
CHLORIDE, SERUM
ADULT: 96-109 MEQ/L
PEDIATRIC: 99-111 MEQ/L
TOP
CHOLESTEROL, SERUM
DESIRABLE CHOLESTEROL IS LESS THAN 200 MG/DL;
BORDERLINE-HIGH CHOLESTEROL IS 200-239 MG/DL;
HIGH CHOLESTEROL IS EQUAL TO OR GREATER THAN 240
MG/DL CATEGORIES ARE BASED UPON THE NATIONAL
CHOLESTEROL EDUCATION PROGRAM RECOMMENDATIONS.
(ARCH INTERN MED 148:36-39, 1988)
CK-ISOENZYMES, ROUTINE
0-7 UG/L
0-3 % INDEX
USE % INDEX WHEN TOTAL CK IS GREATER THAN 1000 IU/L.
CREATINE KINASE (CK), SERUM
FEMALE: 0-150 IU/L (37°C)
MALE: 0-175 IU/L (37°C)
CREATININE, SERUM
ADULT FEMALES: 0.5-1.2 MG/DL
ADULT MALES: 0.6-1.3 MG/DL
TOP
CRYOGLOBULIN SCREEN
NEGATIVE
CSF,VDRL SCREEN
NON-REACTIVE
CYCLOSPORINE
100-275 NG/ML
DESIPRAMINE
150-300 NG/ML
TOP
DIFFERENTIAL, WBC
BAND NEUTROPHILS **
AGE PERCENT
BIRTH - 1 MONTH 0 - 12
1 - 3 MONTHS 0 - 9
3 - 6 MONTHS 0 - 7
6 MONTHS - ADULTS 0- 6
SEGEMENTED NEUTROPHILS **
AGE PERCENT
BIRTH - 1 MONTH 23 - 77
1 - 3 MONTHS 12 - 45
3 - 6 MONTHS 12 - 39
6 MONTHS - 4 YEARS 12 - 41
4 - 6 YEARS 18 - 55
6 - 14 YEARS 24 - 74
14 - 21 YEARS 28 - 78
ADULTS 31 - 76
LYMPHOCYTES **
AGE PERCENT
BIRTH - 1 MONTH 25 - 36
1 - 3 MONTHS 41 - 71
3 - 6 MONTHS 43 - 73
6 - 9 MONTHS 46 - 76
9 MONTHS - 1 YEAR 48 - 78
1 - 2 YEARS 46 - 76
2 - 4 YEARS 45 - 75
4 - 6 YEARS 35 - 65
6 - 14 YEARS 29 - 49
14 - 21 YEARS 28 - 48
ADULTS 24 - 44
MONOCYTES **
AGE PERCENT
BIRTH - 1 MONTH 3 - 9
1 - 3 MONTHS 3 - 12
3 MONTHS - 4 YEARS 3 - 9
4 - 14 YEARS 2 - 10
14 - 21 YEARS 3 - 10
ADULTS 2 - 11
EOSINOPHILS **
AGE PERCENT
ALL AGES 0 - 4
BASOPHILS **
AGE PERCENT
ALL AGES 0 - 2
**IF AGE UNKNOWN, COMPUTER DEFAULTS TO ADULT
RANGES.
TOP
DIGOXIN,SERUM
0.8-2.1 NG/ML
ELECTROLYTE PANEL,SERUM (M6)
REFER TO INDIVIDUAL TESTS.
ELECTROPHORESIS,PROTEIN,SERUM
ADULT:
NORMAL RANGE: (SERUM)
TOTAL PROTEIN -- 6.0 - 8.0 GM/100ML
ALBUMIN -- 3.1 - 5.4 GM/100ML
ALPHA-1-GLOBULIN -- 0.1 - 0.4 GM/100ML
ALPHA-2-GLOBULIN -- 0.4 - 1.1 GM/100ML
BETA GLOBULIN -- 0.5 - 1.2 GM/100ML
GAMMA GLOBULIN -- 0.7 - 1.7 GM/100ML
WRITTEN INTERPRETATION IS PROVIDED BY THE DI
ATTENDING.
TOP
ELECTROPHORESIS,PROTEIN,URINE
WRITTEN INTERPRETATION IS PROVIDED BY THE DI
ATTENDING.
ETHOSUXIMIDE (ZARONTIN),SERUM
THERAPEUTIC RANGE: 40 - 100 MG/L
FIBRINOGEN,QUANT.,EMERGENCY
150-400 MGM/DL IN NON-PREGNANT PATIENTS
FOLATE, SERUM
DEFICIENT: 0.0-3.0 NG/ML
NORMAL: >3.0 NG/ML
FOLATE,RED BLOOD CELL
153-605 NG/ML RBC
FTA-IGM-SERUM
NON-REACTIVE
TOP
GENTAMICIN, ANTIBIOTIC LEVEL
<2MCG/ML PRE DOSE; 4-8 MCG/ML 1 HOUR POST DOSE.
GLUCOSE,SERUM
0 - 7 DAYS: 20-110 MG/DL
7 DAYS-16 YRS: 60-105 MG/DL
ADULTS: 70-115 MG/DL
GLYCOSYLATED HEMOGLOBIN
5.6 - 7.7%
HAPTOGLOBIN/HEMOPEXIN P
HAPTOGLOBIN 100-300 MG/DL (MG%)
HEMOPEXIN 40-100 MG/DL (MG%)
HCG SERUM PREGNANCY (QUANT)
<10 MIU/ML = NEGATIVE
10-25 MIU/ML = INDETERMINATE
>25 MIU/ML = POSITVE
HCG,SERUM (TUMOR MARKER)
<2.0 MIU/ML
TOP
HDL CHOLESTEROL
AGE FEMALES MALES
0-19 YRS 30-70 MG/DL 30-65 MG/DL
20-29 35-75 35-70
30-39 35-80 30-65
40-49 40-85 30-65
50+ 35-85 30-65
HEME-8
LEUKOCYTE COUNT (WBC)
AGE RANGE (X10 3/MM3)
BIRTH - 1 MONTH 9.0 - 30.0
1 - 3 MONTHS 5.0 - 19.5
3 - 6 MONTHS 5.7 - 17.7
6 MONTHS - 2 YEARS 6.0 - 17.5
2 - 4 YEARS 6.0 - 17.0
4 - 8 YEARS 5.5 - 15.5
8 - 14 YEARS 4.5 - 13.5
14 - 21 YEARS 4.5 - 13.0
ADULTS 4.5 - 11.0
ERYTHROCYTE COUNT (RBC)
AGE RANGE ( X10 6/MM3)
MALE FEMALE
BIRTH - 1 DAY 3.9 - 5.5 3.9 - 5.5
1 - 3 DAYS 4.0 - 6.6 4.0 - 6.6
3 - 7 DAYS 3.9 - 6.3 3.9 - 6.3
7 - 14 DAYS 3.6 - 6.2 3.6 - 6.2
14 DAYS - 1 MONTH 3.0 - 5.4 3.0 - 5.4
1 - 2 MONTHS 2.7 - 4.9 2.7 - 4.9
2 - 6 MONTHS 3.1 - 4.5 3.1 - 4.5
6 MONTHS - 2 YEARS 3.7 - 5.3 3.7 - 5.3
2 - 6 YEARS 3.9 - 5.3 3.9 - 5.3
6 - 12 YEARS 4.0 - 5.2 4.0 - 5.2
12 - 18 YEARS 4.5 - 5.3 4.1 - 5.1
ADULTS 4.5 - 5.9 4.0 - 5.2
HEMOGLOBIN (HGB)
AGE RANGE (G/DL)
MALE FEMALE
BIRTH - 2 MONTHS 14.1 - 20.1 14.1 - 20.1
2 - 6 MONTHS 9.0 - 20.0 9.0 - 20.0
6 MONTHS - 4 YEARS 11.6 - 13.6 11.6 - 13.6
4 - 8 YEARS 11.7 - 13.8 11.7 - 13.8
8 - 14 YEARS 12.4 - 14.8 12.4 - 14.8
14 - 21 YEARS 13.2 - 15.6 12.4 - 14.8
ADULTS 13.9 - 16.3 12.0 - 15.0
MEAN CORPUSCULAR HEMOGLOBIN (MCH), ERYTHROCYTE
AGE RANGE ( PG/CELL)
BIRTH - 3 DAYS 31.0 - 37.9
3 DAYS - 1 MONTH 28.0 - 40.0
1 - 2 MONTHS 26.0 - 34.0
2 - 6 MONTHS 25.0 - 35.0
6 MONTHS - 2 YEARS 23.0 - 31.0
2 - 6 YEARS 24.0 - 30.0
6 - 12 YEARS 25.0 - 33.0
12 - 18 YEARS 25.0 - 35.0
ADULTS 26.0 - 34.0
TOP
HEME-8
MEAN CORPUSCULAR VOLUME (MCV), ERYTHROCYTE
AGE RANGE ( FL)
BIRTH - 1 DAY 99.0 - 118.0
1 - 3 DAYS 95.0 - 121.0
3 DAYS - 1 MONTH 86.0 - 124.0
1 - 2 MONTHS 77.0 - 115.0
2 - 6 MONTHS 74.0 - 108.0
6 MONTHS - 2 YEARS 70.0 - 86.0
2 - 6 YEARS 75.0 - 87.0
6 - 12 YEARS 77.0 - 95.0
2 - 18 YEARS 78.0 - 100.0
ADULTS 80.0 - 100.0
PACKED CELL VOLUME (PCV or HCT)
AGE RANGE ( % )
MALE FEMALE
BIRTH - 1 DAY 42.0 - 60.0 42.0 - 60.0
1 - 3 DAYS 45.0 - 67.0 45.0 - 67.0
3 - 7 DAYS 42.0 - 66.0 42.0 - 66.0
7 - 14 DAYS 39.0 - 62.0 39.0 - 62.0
14 DAYS - 1 MONTH 31.0 - 55.0 31.0 - 55.0
1 - 2 MONTHS 28.0 - 42.0 28.0 - 42.0
2 - 6 MONTHS 29.0 - 41.0 29.0 - 41.0
6 MONTHS - 2 YEARS 33.0 - 39.0 33.0 - 39.0
2 - 6 YEARS 34.0 - 40.0 34.0 - 40.0
6 - 12 YEARS 35.0 - 45.0 35.0 - 45.0
12 - 18 YEARS 37.0 - 49.0 36.0 - 46.0
ADULTS 41.0 - 53.0 36.0 - 46.0
TOP
RED CELL DISTRIBUTION WIDTH (RDW)
AGE RANGE ( % )
ALL AGES 11.5 - 14.5
PLATELET COUNT (PLT)
AGE RANGE ( X 10 3/MM3 )
ALL AGES 50 - 350
TOP
IGA,SERUM
SEE IMMUNOGLOBULINS, SERUM.
IGD,SERUM (R.I.D.)
0-14 MG/DL
IGG INDEX,CSF
0.2 - 0.8
COMMENT: >0.8 INDICATES IGG SYNTHESIS IN CNS
IGG,CSF
CHILDREN UNDER 14 YRS: LESS THAN 8.2% IGG/TP
ADULTS: LESS THAN 14% IGG/TP
IGG,SERUM
SEE IMMUNOGLOBULINS, SERUM.
IGM,SERUM
SEE IMMUNOGLOBULINS, SERUM.
IMIPRAMINE (INC DESIPRAMINE)
IMIPRAMINE & DESIPRAMINE 150-250 UG/L
IMMUNOFIXATION-ELECTRO,URINE
WRITTEN INTERPRETATION IS PROVIDED BY THE DI
ATTENDING. PHYSICIANS ARE INVITED TO COME TO THE
DI LAB TO VIEW THE RESULTS OF THE TEST.
IMMUNOFIXATION-ELECTRO.,SERUM
WRITTEN INTERPRETATION IS PROVIDED BY THE DI
ATTENDING. PHYSICIANS ARE INVITED TO COME TO THE
DI LAB TO VIEW THE RESULTS OF THE TEST.
IMMUNOGLOBULIN SURVEY
SEE ELECTROPHORESIS, PROTEIN, SERUM AND
IMMUNOGLOBULINS, SERUM.
TOP
IMMUNOGLOBULINS, SERUM
IGG IGA IGM
AGE (MG/DL) (MG/DL) (MG/DL)
EMORY
WHITE 525-1765 56-400 50-376
BLACK 740-2425 69-546 66-375
HOPKINS
NEWBORN 636-1606 1- 4 6- 25
1- 3 MOS 176- 906 1- 53 17-105
4- 6 MOS 172- 814 4- 84 27-108
7- 9 MOS 217- 904 11- 90 34-126
10-12 MOS 294-1069 16- 84 41-149
1 YR 345-1213 14-106 43-173
2 YRS 424-1051 4-123 48-168
3 YRS 441-1135 22-159 47-200
4- 5 YRS 463-1236 25-154 43-196
6- 8 YRS 633-1280 33-202 48-207
9-10 YRS 608-1572 45-236 52-242
ADULT 639-1349 70-312 56-352
COMPUTER DEFAULT RANGE (IF AGE IS NOT KNOWN):
IGG = 172 - 1606
IGA = 1 - 312
IGM = 6 - 352
TOP
IRON, SERUM
NEWBORN: 100-250 MCG/DL
INFANT: 40-100 MCG/DL
CHLIDREN: 50-120 MCG/DL
ADULT FEMALE: 50-170 MCG/DL
ADULT MALE: 65-170 MCG/DL
ELDERLY: 40-80 MCG/DL
LACTIC DEHYDROGENASE,SERUM
0-220 IU/L (37°C)
LIDOCAINE,SERUM
1.5-5.0 MG/L
LITHIUM, SERUM
0.8-1.5 MEQ/L
MAGNESIUM,SERUM
1.3 - 2.0 MEQ/L
METHEMOGLOBIN
0-1.5% OF TOTAL HB
MITOCHONDRIAL & SMOOTH MUSCLE
NEGATIVE
COMMENT: ANTI-MITOCHONDRIAL AB: SIGNIF TITER 1:10
ANTI-SMOOTH MUSCLE AB: SIGNIF TITER 1:40
TOP
NORTRIPTYLINE
50-150 NG/ML
OSMOLALITY,SERUM
285-295 MOS/KG
PHENOBARBITAL, SERUM
15-40 MG/L
PHENYTOIN (UNBOUND + TOTAL)
1.0 - 2.0 MG/L
5-13% FREE PHENYTOIN
PHENYTOIN,SERUM
THERAPEUTIC RANGE: 10-20 MG/L
PHOSPHATASE, ALKALINE, SERUM
ADULTS: 30-120 IU/L (37°C)
INFANTS: 150-420 IU/L (37°C)
CHILDREN: 100-320 IU/L (37°C)
ADOLESCENT FEMALES: 100-320 IU/L (37°C)
ADOLESCENT MALES: 100-390 IU/L (37°C)
PHOSPHATE, SERUM
ADULTS (16+ YEARS): 2.7-4.5 MG/DL
CHILDREN (0-15 YEARS): 3.2-6.3 MG/DL
PREALBUMIN,SERUM
NEWBORN: 4-34 MG/DL
6 WKS - 14 YRS: 12-25 MG/DL
ADULT: 8-31 MG/DL
TOP
PRIMIDONE AND METAB.,SERUM
PRIMIDONE: 5-12 MG/L
PHENOBARB: 15-40 MG/L
PROCAINAMIDE & NAPA
PROCAINAMIDE: 4-10 MG/L
NAPA: 6-20 MG/L
PROCAINAMIDE & N-ACETYPROCAINAMIDE: 10-30 MG/L
PROSTATE SPECIFIC ANTIGEN(PSA)
0-2.8 NG/ML(HEALTHY MEN)
POST PROSTATECTOMY: <0.2 NG/ML
PROTEIN QUANT.,URINE (24 HR)
25-100 MG/24 HR
PROTEIN, TOTAL, SERUM
>2 YEARS: 6.0-8.2 G/DL
PROTHROMBIN TIME
11.3 - 12.5 SECONDS
PTH-INTACT (1-84)
10-65 PG/ML
QUINIDINE, SERUM
2.0-5.0 MG/L
RETICULOCYTE COUNT
AGE RANGE ( % ) ABSOLUTE COUNT
BIRTH - 1 MONTH 2.0 - 4.0 100000 - 200000
1 - 3 MONTHS 0.4 - 0.8 14000 - 28000
3 - 6 MONTHS 0.5 - 0.9 19000 - 34200
6 MONTHS - ADULT 0.5 - 1.5 25000 - 75000
TOP
SALICYLATE, SERUM
THERAPEUTIC 20-100 MG/L
ANTI-INFLAMMATORY 100-300 MG/L
SODIUM AND POTASSIUM, SERUM
SODIUM: 135-148 MEQ/L
POTASSIUM: 3.5-5.0 MEQ/L
NEWBORNS: 4.0-5.9 MEQ/L
STS & FTA-ABS
NON-REACTIVE.
STS-EMERGENCY (RPR SCN+TR)
NON-REACTIVE
SYPH.SERO: RPR SCREEN & TITER
NON-REACTIVE
THEOPHYLLINE, SERUM
THERAPEUTIC RANGE: 10-20 MG/L
THROMBIN TIME,EMERGENCY
14.5 - 18.9 SECONDS
TOBRAMYCIN, ANTIBIOTIC LEVEL
PRE-DOSE <2 MCG/ML POST-DOSE (1 HR)
4-8 MCG/ML
TRANSFERRIN,SERUM (WITH IRON)
TRANSFERRIN: 200-400 MG/DL
IRON: SEE IRON, SERUM
TRICYCLICS, TOTAL, EMER.
<100 NG/ML PROBABLY SUB-THERUAPEUTIC
100-300 NG/ML PROBABLY THERAPEUTIC
500-1000 NG/ML POSSIBLY TOXIC
>1000 NG/ML TOXIC
TOP
UREA NITROGEN, SERUM
7-22 MG/DL
URIC ACID,SERUM
ADULT FEMALES: 2.4-6.4 MG/DL
ADULT MALES: 3.5-7.2 MG/DL
CHILDREN: 2.0-5.5 MG/DL
VALPROIC ACID, SERUM
THERAPEUTIC RANGE: 50-100 MG/L
VANCOMYCIN, ANTIBIOTIC LEVEL
10-40 MCG/ML 1 HOUR POST DOSE.
_______________________________________________________________________________________________________ TOP _______________________________________________________________________________________________________
Emory University Hospital Department of Pathology